Cellectar Biosciences, Inc. · NASDAQ:CLRB
Caligan Partners LP reported a 5.90% stake in Cellectar Biosciences, Inc. (Schedule 13G)
Event Jun 30, 2026 · Filed Aug 14, 2026
Caligan Partners LP reported a 5.90% stake in Cellectar Biosciences, Inc., 469,998 shares, as a passive investor on Jun 30, 2026. Filed Aug 14, 2026 (Schedule 13G).
- Stake
- 5.90%
- Shares
- 469,998
- Intent
- Passive
- What changed
- Crossed above 5%
- Filed together
- 2 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Caligan Partners LP | 5.90% | 469,998 |
| JOHNSON DAVID EDWARD | 5.90% | 469,998 |
Source
Related
- Cellectar Biosciences, Inc.
- Caligan Partners LP
- Cellectar Biosciences, Inc. shareholders
- Schedule 13G · Stempoint Capital LP · Aug 14, 2026
- Schedule 13G · Silverarc Capital Management, LLC · Aug 14, 2026
- Schedule 13G · Balyasny Asset Management L.P. · Aug 14, 2026
- Schedule 13G · Bleichroeder LP · Aug 13, 2026
- Schedule 13G · Empery Asset Management, LP · Aug 4, 2026